Online Only Articles

Deltex-1 mutations predict poor survival in diffuse large B-cell lymphoma

Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
Department of Pathology, Helsinki University Hospital, Finland
Department of Oncology, Oslo University Hospital, Norway
Department of Pathology, University of Toronto, ON, Canada;Department of Pathology, Oslo University Hospital, Norway
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland
Research Programs Unit, Genome-Scale Biology Program, Faculty of Medicine, University of Helsinki, Finland;Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Finland
Vol. 102 No. 5 (2017): May, 2017 https://doi.org/10.3324/haematol.2016.157495